Cholera: A great global concern

Asian Pacific Journal of Tropical Medicine

Volumn 4, Issue 7, 2011, Pages 573-580

  Mandal, Shyamapada ^a   Mandal, Manisha Deb ^b   Pal, Nishith Kumar ^c  

^a GURUDAS COLLEGE   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

^c INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cholera; Cholera vaccine; Multidrug resistance; Pandemics epidemics outbreaks; Toxigenic Vibrio cholerae

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CHOLERA TOXIN; CHOLERA VACCINE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FURAZOLIDONE; NALIDIXIC ACID; NEOMYCIN; STREPTOMYCIN; TETRACYCLINE; TRIMETHOPRIM;

ARTICLE; BIOTYPE; BLOOD GROUP TYPING; CHOLERA; CLINICAL FEATURE; DISEASE COURSE; DISEASE TRANSMISSION; EPIDEMIC; GENE CONVERSION; HUMAN; INCIDENCE; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; PANDEMIC; PREVALENCE; PRIORITY JOURNAL; REHYDRATION; SEROTYPE; SINGLE DRUG DOSE; VIBRIO CHOLERAE;

ANTI-BACTERIAL AGENTS; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; DEVELOPING COUNTRIES; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUID THERAPY; HUMANS; PUBLIC HEALTH; VIBRIO CHOLERAE;

EID: 79960886579     PISSN: 19957645     EISSN: 19957645     Source Type: Journal    
DOI: 10.1016/S1995-7645(11)60149-1     Document Type: Article

References (67)

1. Sack DA, Sack RB, Chaignat CL Getting serious about cholera. N Engl J Med 2006, 355:649-651.
2. World Health Organization Cholera 2006. Wkly Epidemiol Rec 2007, 82:273-284.
3. Goel AK, Jain M, Kumar P, Jiang SC Molecular characterization of Vibrio cholerae outbreak strains with altered El Tor biotype from southern India. World J Microbiol Biotechnol 2010, 26:281-287.
4. Koelle K, Pascual M, Yunus M Pathogen adaptation to seasonal forcing and climate change. Proc Royl Soc B 2005, 272:971-977.
5. Laws E Case study: cholera. Oceanography 2006, 19:81-83.
6. Colwell RR A voyage of discovery: cholera, climate and complexity. Environ Microbiol 2002, 4:67-69.
7. World Health Organization Cholera: global surveillance summary, 2008. Wkly Epidemiol Rec 2009, 84:309-324.
8. Ramamurthy T, Nair GB Evolving identity of epidemic Vibrio cholerae: past and the present. Sci Cult 2010, 76:153-159.
9. Nair GB, Albert MJ, Shimada T, Takeda Y Vibrio cholerae O139 Bengal: the new serogroup causing cholera. Rev Med Microbiol 1996, 7:43-51.
10. Mukhopadhyay AK, Basu A, Garg P, Bag PK, Ghosh A, Bhattacharya SK Molecular epidemiology of reemergent Vibrio cholerae O139 Bengal in India. J Clin Microbiol 1998, 36:2149-2152.
11. Safa A, Sultana J, Dac Cam P, Mwansa JC, Kong RY Vibrio cholerae O1 hybrid El Tor strains, Asia and Africa. Emerg Infect Dis 2008, 14:987-988.
12. Nishibori T, de Vries GC, Rahardjo D, Wasito EB, De I, Kinoshita S, et al. Phenotypic and genotypic characterization of Vibrio cholerae clinically isolated in Surabaya, Indonesia. Jpn J Infect Dis 2011, 64:7-12.
13. Goel AK, Jain M, Kumar P, Bhadauria S, Kmboj DV, Singh L A new variant of Vibrio cholerae O1 El Tor causing cholera in India. J Infect 2008, 57:280-281.
14. Chatterjee S, Ghosh K, Raychoudhuri A, Pan A, Bhattacharya MK, Mukhopadhyay AK Phenotypic and genotypic traits and epidemiological implication of Vibrio cholerae O1 and O139 strains in India during 2003. J Med Microbiol 2007, 56:824-832.
15. Jabeen K, Zafar A, Hasan R Increased isolation of Vibrio cholerae O1 serotype Inaba over serotype Ogawa in Pakistan. Eastern Mediter Health J 2008, 14:564-570.
16. Roychowdhury A, Pan A, Dutta D, Mukhopadhyay AK, Ramamurthy T, Nandy RK Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India. Jpn J Infect Dis 2008, 61:128-129.
17. Faruque SM, Naser IB, Islam MJ Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc Natl Acad Sci USA 2005, 102:1702-1707.
18. Dutta B, Ghosh R, Sharma NC, Pazhani GP, Taneja N, Raychowdhuri A Spread of cholera with newer clones of Vibrio cholerae O1 El Toe, serotype Inaba, in India. J Clin Microbiol 2006, 44:3391-3393.
19. Faruque SM, Chowdhury N, Kamruzzaman M Reemergence of epidemic Vibrio cholerae O139, Bangladesh. Emerg Infect Dis 2003, 9:1116-1122.
20. Infectious disease epidemiology section: office of public health, louisiana. Cholera and other vibrios.[Online] [accessed on 2006]. http://www.infectiousdisease.dhh.louisiana.gov.
21. World Health Organisation Cholera. Fact sheet no. 107.[Online] [Accessed on 2006]. http://www.who.int/mediacentre/factsheets/fs107/en.
22. Ruiz-Moreno D, Pascual M, Emch M, Yunus M Spatial clustering in the spatio-temporal dynamics of endemic cholera. BMC Infect Dis 2010, 10:51.
23. Hartely DM, Glenn MJ, Smith DL Hyperinfectivity: a critical element in the ability of Vibrio cholerae to cause epidemics?. PLoS Med 2006, 3:e7.
24. Sack DA, Sack RB, Nair GB, Siddique AK Cholera. Lancet 2004, 363:223-233.
25. Pascual M, Koelle K, Dobson AP Hyperinfectivity in cholera: a new mechanism for an old epidemiological model?. PLoS Med 2006, 3:e280.
26. Chandrasekhar ME, Krishna BVS, Patil AB Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups. Southeast Asian J Trop Med Public Health 2008, 39:1092-1097.
27. Das S, Saha R, Kaur IR Trend of antibiotic resistance of Vibrio cholerae strains from east Delhi. Indian J Med Res 2008, 127:478-482.
28. Pal BB, Khuntia HK, Samal SK, Das SS, Chhotray GP Emergence of Vibrio cholerae O1 Biotype El Tor Serotype Inaba causing outbreaks of cholera in Orissa, India. Jpn J Infect Dis 2006, 59:266-269.
29. Kanungo S, Sah BK, Lopez AL, Sung JS, Paisley AM, Sur D Cholera in India: an analysis of reports, 1997-2006. Bull World Health Organ 2010, 88:185-191.
30. Sur D, Deen J, Manna B, Niyogi SK, Deb A, Kanungo S The burden of cholera in the slums of Kolkata, India: from a prospective, community-based study. Arch Dis Child 2005, 90:1175-1181.
31. Sur D, Sarkar BL, Manna B, Deen J, Datta S, Niyogi SK Epidemiological, microbiological and electron microscopic study of a cholera outbreak in a Kolkata slum community. Indian J Med Res 2006, 113:31-36.
32. Sur D, Dutta S, Sarkar BL, Manna B, Bhattacharya MK, Datta KK Occurrence, significance and molecular epidemiology of cholera outbreaks in West Bengal. Indian J Med Res 2007, 125:772-776.
33. Mandal S, Mandal MD, Pal NK Plasmid mediated antibiotic resistance of Vibrio cholerae O1 biotype El Tor serotype Ogawa associated with an outbreak in Kolkata, India. Asian Pacific J Trop Med 2010, 3:637-641.
34. Tavana A Cholera outbreaks in Iran and duration time of outbreaks. J Glob Infect Dis 2009, 1:75-76.
35. Shah M, Faruque M, Islam J, Ahmad QS, Biswas K, Faruque ASG An improved technique for isolation of environmental Vibrio cholerae with epidemic potential: monitoring the emergence of a multiple-antibiotic-resistant epidemic Strain in Bangladesh. J Infect Dis 2006, 193:1029-1036.
36. Siddiqui FJ, Bhutto NS, von Seidlin L, Khurram I, Rasool S, Ali M Consecutive outbreaks of Vibrio cholerae O139 and Vibrio cholerae O1 cholera in a fishing village near Karachi, Pakistan. Trans R Soc Trop Med Hyg 2006, 100:476-482.
37. Karki R, Bhatta DR, Malla S, Dumre SP Cholera incidence among patients with diarrhea visiting National public health laboratory, Nepal. Jpn J Infect Dis 2010, 63:185-187.
38. Alam M, Hasan NA, Sadique A, Bhuiyan NA, Ahmed KN, Nusnin S Seasonal cholera caused by Vibrio cholerae serogroups O1 and O139 in the coastal aquatic environment of Bangladesh. Appl Environ Microbiol 2006, 72:4096-4104.
39. World Health Organisation Cholera, 2005. Wkly Epidemiol Rec 2006, 81:297-307.
40. Anon Health ministry urges to strengthen control of cholera. [Online] [Accessed on 2006]. http://news3.xinhuanet.com/english/2006-05/15/content_4548642.htm.
41. World Health Organisation Cholera, 2004. Wkly Epidemiol Rec 2005, 80:261-268.
42. Bhattacharya S, Black R, Bourgeois L Public health: the cholera crisis in Africa. Science 2009, 324:885.
43. Harris JB, Larocque RC, Charles RC, Mazumder RN, Khan AI, Bardhan PK Cholera's western front. Lancet 2010, 376(9757):1961-1965.
44. World Health Organisation World health statistics 2010. [Online] [Accessed on 2010]. http://www.who.int/whosis/whostat/EN_WHS10_Full.pdf.
45. Pan American Health Organization Epidemiological alert: update on the situation in Haiti. [Online] [Accessed on 2010]. http://new.paho.org/hq/index2.php?option=com_docman&task=doc_view&gid=11125&Itemid=1091.
46. World Health Organisation The treatment of diarrhoea: a manual for physicians and other senior health workers. [Online] [Accessed on 2010]. http://whqlibdoc.who.int/publications/2005/9241593180.pdf.
47. Ryan ET, Dhar U, Khan WA Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am J Trop Med Hyg 2000, 63:12-20.
48. Hossain MS, Salam MA, Rabbani GH, Kabir I, Biswas R, Mahalanabis D Tetracycline in the treatment of severe cholera due to Vibrio cholerae O139 Bengal. J Health Popul Nutr 2002, 20:18-25.
49. Saha D, Karim MM, Khan WA, Ahmed S, Salam MA, Bennish ML Single-dose azithromycin for the treatment of cholera in adults. New Engl J Med 2006, 354:2452-2462.
50. Seas C Vibrio cholerae. Principles and practice of infectious diseases 2005, 2536-2544. Churchill Livingstone, Philadelphia. 6th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
51. Bhattacharya MK, Dutta D, Ramamurthy T, Sarkar D, Singharoy A, Bhattacharya SK Azithromycin in the treatment of cholera in children. Acta Paediatr 2003, 92:676-678.
52. Saha D, Khan WA, Karim MM, Chowdhury HR, Salam MA, Bennish ML Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. Lancet 2005, 366:1085-1093.
53. Mandal S, Mandal MD, Pal NK Combination effect of ciprofloxacin and gentamicin against clinical isolates of Salmonella enterica serovar Typhi with reduced susceptibility to ciprofloxacin. Jpn J Infect Dis 2003, 56:156-157.
54. Mandal S, DebMandal M, Pal NK Synergism of ciprofloxacin and trimethoprim against Salmonella enterica serovar Typhi isolates showing reduced susceptibility to ciprofloxacin. Chemotherapy 2004, 50:152-154.
55. Mandal S, Pal NK, Chowdhury IH, DebMandal M Antibacterial activity of ciprofloxacin and trimethoprim, alone and in combination, against Vibrio cholerae O1 biotype El Tor serotype Ogawa isolates. Polish J Microbiol 2009, 58:57-60.
56. Faruque SM, Saha MN, Asadulghani, Bag PK, Bhattacharya SK, Sach RB Genomic diversity among Vibrio cholerae O139 strains isolated in Bangladesh and India between 1992 and 1998. FEMS Microbiol Lett 2000, 184:279-284.
57. Faruque AS, Alam K, Malek MA, Khan MG, Ahmed S, Saha D Emergence of multidrug-resistant strain of Vibrio cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after two years. J Health Popul Nutr 2007, 25:241-243.
58. Pugliese N, Maimone F, Scrascia M, Materu SF, Pazzani C SXT-related integrating conjugative element and IncC plasmids in Vibrio cholerae O1 strains in Eastern Africa. Antimicrob Agents Chemother 2009, 63:438-442.
59. Reid AJ, Amyes SGB Plasmid penicillin resistance in Vibrio cholerae: identification of new beta-lactamase SAR-1. Antimicrob Agents Chemother 1986, 30:245-247.
60. Mwansa JCL, Mwaba J, Lukwesa C, Bhuiyan NA, Ansaruzzaman M, Ramamurthy T Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia. Epidemiol Infect 2007, 135:847-853.
61. Manna B, Niyogi SK, Bhattacharya MK, Sur D, Bhattacharya SK Observations from diarrhoea surveillance support the use of cholera vaccination in endemic areas. Int J Infect Dis 2005, 9:117-119.
62. Page KE Cholera: mechanism of infection, history and treatment. South Carolina J Mol Med 2004, 5:26-29.
63. Ali M, Emch M, von Seidlein L Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 2005, 366:44-49.
64. Ghose AC Immunity in cholera and vaccine development: problems and prospects. Sci Cult 2010, 76:166-172.
65. Calain P, Chaine JP, Johnson E Can oral cholera vaccination play a role in controlling a cholera outbreak?. Vaccine 2004, 22:2444-2451.
66. Lucas ME, Deen JL, von Seidlein L Effectiveness of mass oral cholera vaccination in Beira, Mozambique. New Engl J Med 2005, 352:757-767.
67. Richie EE, Punjabi NH, Sidharta YY Efficacy trial of singledose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 2000, 18:2399-2410.